[MYGN] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 165.38%
YoY- -39.47%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 164,900 173,100 164,000 216,600 193,500 196,900 190,500 -2.37%
PBT -26,400 -49,600 -131,100 3,300 16,500 8,000 43,100 -
Tax -5,900 -10,100 -15,900 -3,600 5,200 3,800 10,500 -
NP -20,500 -39,500 -115,200 6,900 11,400 4,200 32,600 -
Tax Rate - - - 109.09% -31.52% -47.50% -24.36% -
Total Cost 185,400 212,600 279,200 209,700 182,100 192,700 157,900 2.71%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -12.43 -22.82 -70.24 3.19 5.89 2.13 17.11 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.26 -0.52 -1.55 0.09 0.16 0.06 0.49 -
EPS Diluted -0.26 -0.52 -1.55 0.09 0.16 0.06 0.47 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.